Patent Assignment
Reel/Frame 060859/0953
Assignment of Assignor's Interest
Recorded: 2022-08-22
Pages: 10
Assignors
BY, KOLBOT
Executed: 2022-07-11
CHU, KATHERINE
Executed: 2022-05-18
MASJEDIZADEH, MOHAMMED
Executed: 2022-05-30
PHIASIVONGSA, PASIT
Executed: 2022-07-12
ZHU, JIANG
Executed: 2022-07-14
Assignee
PRINCIPIA BIOPHARMA INC.
220 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Properties
(2)
Solid Forms of 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxyphenyl)Pyrazolo[3,4-D]Pyrimidin-1-Yl]Piperidine-1-Carbonyl]-4-Methyl-4-[4-(Oxetan-3-Yl)Piperazin-1-Yl]Pent-2-Enenitrile
Solid Forms of 2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy-Phenyl)Pyrazolo[3,4-D]Pyrimidin-1-Yl]Piperidine-1-Carbonyl]-4-Methyl-4-[4-(Oxetan-3-Yl)Piperazin-1-Yl]Pent-2-Enenitrile
Application:
62/951,958 →
PCT:
PCT/US2020/065689 ↗
Related Assignments
(2)
Other recorded transfers of the patents in this record — the chain of ownership.
Corrective Assignment to Correct the the Application Number from 63122209 to 63122309 Previously Recorded at Reel: 060859 Frame: 0953. Assignor(S) Hereby Confirms the Assignment.
Aug 24, 2022
From: BY, KOLBOT; CHU, KATHERINE; MASJEDIZADEH, MOHAMMED; PHIASIVONGSA, PASIT
To: PRINCIPIA BIOPHARMA INC.
Reel/Frame 061313/0008 →
Assignee Change of Address
Sep 16, 2025
From: PRINCIPIA BIOPHARMA INC.
To: PRINCIPIA BIOPHARMA INC.
Reel/Frame 072881/0270 →